Clinical Trial Update: Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study comparing lixisenatide with liraglutide on postprandial plasma glucose in patients with Type 2 Diabetes Mellitus; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Adlyxin (lixisenatide)
• Victoza (Liraglutide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2016-10-11